Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Cindy Strehl; Johannes W. J. Bijlsma; Maarten de Wit; Maarten Boers; Nele Caeyers; Maurizio Cutolo; Bhaskar Dasgupta; William G. Dixon; Rinie Geenen; Tom W. J. Huizinga; Alison Kent; Annette Ladefoged de Thurah; Joachim Listing; Xavier Mariette; David W. Ray; Hans U. Scherer; Raphaele Seror; Cornelia M. Spies; Simon Tarp; Dieter Wiek; Kevin L. Winthrop; Frank Buttgereit

doi:https://doi.org/10.1136/annrheumdis-2015-208916

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Cindy Strehl, Johannes W. J. Bijlsma, Maarten de Wit, Maarten Boers, Nele Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G. Dixon, Rinie Geenen, Tom W. J. Huizinga, Alison Kent, Annette Ladefoged de Thurah, Joachim Listing, Xavier Mariette, David W. Ray, Hans U. Scherer, Raphaele Seror, Cornelia M. Spies, Simon Tarp, Dieter WiekKevin L. Winthrop, Frank Buttgereit

Research output: Contribution to journal › Article › Academic › peer-review

253 Citations (Scopus)

Original language	English
Pages (from-to)	952-957
Journal	Annals of the rheumatic diseases
Volume	75
Issue number	6
DOIs	https://doi.org/10.1136/annrheumdis-2015-208916
Publication status	Published - Jun 2016

Access to Document

https://doi.org/10.1136/annrheumdis-2015-208916

Cite this

Strehl, C., Bijlsma, J. W. J., de Wit, M., Boers, M., Caeyers, N., Cutolo, M., Dasgupta, B., Dixon, W. G., Geenen, R., Huizinga, T. W. J., Kent, A., de Thurah, A. L., Listing, J., Mariette, X., Ray, D. W., Scherer, H. U., Seror, R., Spies, C. M., Tarp, S., ... Buttgereit, F. (2016). Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Annals of the rheumatic diseases, 75(6), 952-957. https://doi.org/10.1136/annrheumdis-2015-208916

@article{95f998bd5c88443f953aae1c06ac203f,

title = "Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force",

author = "Cindy Strehl and Bijlsma, {Johannes W. J.} and {de Wit}, Maarten and Maarten Boers and Nele Caeyers and Maurizio Cutolo and Bhaskar Dasgupta and Dixon, {William G.} and Rinie Geenen and Huizinga, {Tom W. J.} and Alison Kent and {de Thurah}, {Annette Ladefoged} and Joachim Listing and Xavier Mariette and Ray, {David W.} and Scherer, {Hans U.} and Raphaele Seror and Spies, {Cornelia M.} and Simon Tarp and Dieter Wiek and Winthrop, {Kevin L.} and Frank Buttgereit",

year = "2016",

month = jun,

doi = "https://doi.org/10.1136/annrheumdis-2015-208916",

language = "English",

volume = "75",

pages = "952--957",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "6",

}

Strehl, C, Bijlsma, JWJ, de Wit, M, Boers, M, Caeyers, N, Cutolo, M, Dasgupta, B, Dixon, WG, Geenen, R, Huizinga, TWJ, Kent, A, de Thurah, AL, Listing, J, Mariette, X, Ray, DW, Scherer, HU, Seror, R, Spies, CM, Tarp, S, Wiek, D, Winthrop, KL & Buttgereit, F 2016, 'Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force', Annals of the rheumatic diseases, vol. 75, no. 6, pp. 952-957. https://doi.org/10.1136/annrheumdis-2015-208916

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. / Strehl, Cindy; Bijlsma, Johannes W. J.; de Wit, Maarten et al.
In: Annals of the rheumatic diseases, Vol. 75, No. 6, 06.2016, p. 952-957.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

AU - Strehl, Cindy

AU - Bijlsma, Johannes W. J.

AU - de Wit, Maarten

AU - Boers, Maarten

AU - Caeyers, Nele

AU - Cutolo, Maurizio

AU - Dasgupta, Bhaskar

AU - Dixon, William G.

AU - Geenen, Rinie

AU - Huizinga, Tom W. J.

AU - Kent, Alison

AU - de Thurah, Annette Ladefoged

AU - Listing, Joachim

AU - Mariette, Xavier

AU - Ray, David W.

AU - Scherer, Hans U.

AU - Seror, Raphaele

AU - Spies, Cornelia M.

AU - Tarp, Simon

AU - Wiek, Dieter

AU - Winthrop, Kevin L.

AU - Buttgereit, Frank

PY - 2016/6

Y1 - 2016/6

U2 - https://doi.org/10.1136/annrheumdis-2015-208916

DO - https://doi.org/10.1136/annrheumdis-2015-208916

M3 - Article

C2 - 26933146

SN - 0003-4967

VL - 75

SP - 952

EP - 957

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 6

ER -

Strehl C, Bijlsma JWJ, de Wit M, Boers M, Caeyers N, Cutolo M et al. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Annals of the rheumatic diseases. 2016 Jun;75(6):952-957. doi: https://doi.org/10.1136/annrheumdis-2015-208916